ES2009907A6 - Procedimiento para detectar en sangre humana la presencia de anticuerpos frente al virus sida. - Google Patents

Procedimiento para detectar en sangre humana la presencia de anticuerpos frente al virus sida.

Info

Publication number
ES2009907A6
ES2009907A6 ES8801339A ES8801339A ES2009907A6 ES 2009907 A6 ES2009907 A6 ES 2009907A6 ES 8801339 A ES8801339 A ES 8801339A ES 8801339 A ES8801339 A ES 8801339A ES 2009907 A6 ES2009907 A6 ES 2009907A6
Authority
ES
Spain
Prior art keywords
procedure
human blood
antibodies against
detect
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8801339A
Other languages
English (en)
Inventor
Wilhelm Bannwarth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES2009907A6 publication Critical patent/ES2009907A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA DETECTAR EN SANGRE HUMANA LA PRESENCIA DE ANTICUERPOS FRENTE AL VIRUS SIDA. EN ESTE PROCEDIMIENTO SE USA UN POLIPEPTIDO QUE COMPRENDE UNA SECUENCIA DE AMINOACIDO REPRESENTADA POR LA FORMULA (I), O SUS FRAGMENTOS, QUE PROPORCIONA ANTICUERPOS FRENTE A VIRUS DE SIDA Y/O REACCION CON SIDA-ANTICUERPOS O POLIPEPTIDOS INMUNOLOGENICOS Y/O ANTIGENICOS RELATIVOS A CUALQUIERA DE LOS POLIPEPTIDOS PRECEDENTES MEDIANTE SUSTITUCION O SUSTITUCIONES DE AMINOACIDOS. EL PROCEDIMIENTO CONSISTE EN HACER REACCIONAR EL POLIPEPTIDO ANTERIORMENTE DESCRITO CON UNA MUESTRA DE SANGRE HUMANA, Y DETERMINAN SI DICHOS POLIPEPTIDOS LIGAN ANTICUERPOS DE SIDA PRESENTAR EN LA MUESTRA DE SANGRE.
ES8801339A 1985-10-17 1988-04-29 Procedimiento para detectar en sangre humana la presencia de anticuerpos frente al virus sida. Expired ES2009907A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858525615A GB8525615D0 (en) 1985-10-17 1985-10-17 Polypeptides

Publications (1)

Publication Number Publication Date
ES2009907A6 true ES2009907A6 (es) 1989-10-16

Family

ID=10586812

Family Applications (7)

Application Number Title Priority Date Filing Date
ES8602630A Expired ES2009210A6 (es) 1985-10-17 1986-10-16 Un procedimiento para la obtencion de nuevos polipeptidos que proporcionan anticuerpos frente a virus de sida, yno reaccionantes con anticuerpos sida.
ES8801337A Expired ES2009905A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de anticuerpos frente a virus de sida.
ES8801340A Expired ES2006925A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de vectores de expresion.
ES8801339A Expired ES2009907A6 (es) 1985-10-17 1988-04-29 Procedimiento para detectar en sangre humana la presencia de anticuerpos frente al virus sida.
ES8801342A Expired ES2010538A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de un gen sintetico.
ES8801341A Expired - Lifetime ES2014527A6 (es) 1985-10-17 1988-04-29 Procedimiento para la determinacion de virus sida.
ES8801338A Expired ES2009906A6 (es) 1985-10-17 1988-04-29 Procedimiento de preparacion de transformantes bacterianos.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES8602630A Expired ES2009210A6 (es) 1985-10-17 1986-10-16 Un procedimiento para la obtencion de nuevos polipeptidos que proporcionan anticuerpos frente a virus de sida, yno reaccionantes con anticuerpos sida.
ES8801337A Expired ES2009905A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de anticuerpos frente a virus de sida.
ES8801340A Expired ES2006925A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de vectores de expresion.

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES8801342A Expired ES2010538A6 (es) 1985-10-17 1988-04-29 Procedimiento para la preparacion de un gen sintetico.
ES8801341A Expired - Lifetime ES2014527A6 (es) 1985-10-17 1988-04-29 Procedimiento para la determinacion de virus sida.
ES8801338A Expired ES2009906A6 (es) 1985-10-17 1988-04-29 Procedimiento de preparacion de transformantes bacterianos.

Country Status (11)

Country Link
EP (1) EP0219106A3 (es)
JP (1) JPS6299398A (es)
AU (1) AU602315B2 (es)
BR (1) BR8605053A (es)
DK (1) DK496486A (es)
ES (7) ES2009210A6 (es)
GB (1) GB8525615D0 (es)
IL (1) IL80304A0 (es)
NO (1) NO864139L (es)
NZ (1) NZ217895A (es)
ZA (1) ZA867748B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76082A (en) * 1984-08-22 1991-07-18 Us Health Molecular clones of the genome of htlv-iii and a process for the preparation thereof
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
EP0247557B1 (en) * 1986-05-27 1994-04-20 F. Hoffmann-La Roche Ag HTLV-III(LAV) Envelope peptides
WO1987007616A1 (en) * 1986-06-12 1987-12-17 Biogen N.V. Peptides involved in the pathogenesis of hiv infection
US5087557A (en) * 1986-06-23 1992-02-11 Genetic Systems Corporation Human monoclonal antibody to lymphadenopathy-associated virus
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
GB8714802D0 (en) * 1987-06-24 1987-07-29 Proteus Biotech Ltd Synthetic polypeptides
IL87391A0 (en) * 1987-08-27 1989-01-31 Repligen Corp Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
EP0323157A3 (en) * 1987-12-24 1990-07-25 The University Of Melbourne Antiviral compounds and methods
US6214537B1 (en) 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6218102B1 (en) * 1988-01-27 2001-04-17 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
AU629528B2 (en) * 1988-01-27 1992-10-08 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting hiv antibodies
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
SE8802176D0 (sv) * 1988-06-10 1988-06-10 Kabigen Ab Fusion protein and its use
IL91462A0 (en) * 1988-08-30 1990-04-29 Applied Research Systems Recombinant fusion proteins and dna encoding for such a protein
ATE118247T1 (de) * 1988-09-27 1995-02-15 Dana Farber Cancer Inst Inc Vektor, der ein replikationskompetentes hiv-i- provirus und ein heterologes gen enthält.
US6228608B1 (en) * 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
US6316004B1 (en) * 1993-06-22 2001-11-13 T. Tikhonenko Chimeric somatostatin containing protein and encoding DNA, plasmids of expression, method for preparing chimeric protein, strain-producers, immunogenic composition, method for increasing the productivity of farm animals
IT1271486B (it) * 1993-10-12 1997-05-28 Italfarmaco Spa Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
FR2732346B1 (fr) * 1995-03-27 1997-05-30 Centre Nat Rech Scient Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
CA2288869A1 (en) * 1998-03-04 1999-09-10 Mary Ann Childs Rapid confirmatory test for microbial infections
ATE508139T1 (de) 2003-04-11 2011-05-15 Pasteur Institut Synthetische peptid-hiv-vakzine: das cbd-epitop als effizientes immunogen zur induktion hiv- neutralisierender antikörper
EP3461813A1 (en) 2004-05-23 2019-04-03 Gerard M. Housey Theramutein modulators
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
EP0387915B1 (en) * 1984-10-18 1993-03-10 Institut Pasteur F antigens of the human immunodeficiency virus, and their applications
DE3588134T2 (de) * 1984-12-24 1997-03-20 Genentech Inc Fusionen von AIDS-verwandten Polypeptiden
US4774175A (en) * 1985-03-01 1988-09-27 Centocor, Inc. Immunochemical methods for the detection of antibody against HTLV-III
EP0220273B2 (en) * 1985-04-29 2007-01-17 Bio-Rad Laboratories, Inc. Synthetic antigens for the detection of aids-related disease

Also Published As

Publication number Publication date
IL80304A0 (en) 1987-01-30
ES2010538A6 (es) 1989-11-16
EP0219106A3 (en) 1989-02-08
EP0219106A2 (en) 1987-04-22
JPS6299398A (ja) 1987-05-08
NO864139D0 (no) 1986-10-16
ES2009906A6 (es) 1989-10-16
GB8525615D0 (en) 1985-11-20
DK496486A (da) 1987-04-18
ES2014527A6 (es) 1990-07-16
DK496486D0 (da) 1986-10-16
BR8605053A (pt) 1987-07-14
AU6399786A (en) 1987-04-30
ZA867748B (en) 1987-07-29
NO864139L (no) 1987-04-21
ES2009905A6 (es) 1989-10-16
ES2006925A6 (es) 1989-05-16
NZ217895A (en) 1991-05-28
AU602315B2 (en) 1990-10-11
ES2009210A6 (es) 1989-09-16

Similar Documents

Publication Publication Date Title
ES2009907A6 (es) Procedimiento para detectar en sangre humana la presencia de anticuerpos frente al virus sida.
ES2016426A6 (es) Un procedimiento para detectar la presencia de anticuerpos frente a virus del sida en el suero humano.
DK626486D0 (da) Syntetiske antigener til afslaering af aids-relateret sygdom
ES2076142T3 (es) Peptidos para el diagnostico de anticuerpos para htlv-iii, su preparacion y uso.
DK161015C (da) Blanding til anvendelse ved ekstern paavisning og lokalisering af en blodprop
ES8801839A1 (es) Procedimiento para detectar anticuerpos a htlv-iii y diagnosticar aids, arc o estados pre-aids
FI870447A0 (fi) Htlv-iii-hoeljepeptider.
ATE87655T1 (de) Markierer der t-zelle aktivierung.
EP0446273A4 (en) Monoclonal antibodies to feline-t-lymphotropic lentivirus
DK645887D0 (da) Gamma-hesteinterferon, fremgangsmaade til fremstilling af, samt anvendelse af en saadan forbindelse
ATE69108T1 (de) Elektrophoretisches gel hoher aufloesung sowie methode zur abscheidung von serumproteinen.
DK611386A (da) Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden
ES2066887T3 (es) Anticuerpo monoclonal para diferenciar individuos seropositivos hiv-2 de los hiv-1.
SE8802944L (sv) Material foer lapptestning
El-Maliki et al. Structural homology between glycophorins C and D of human erythrocytes
ATE46703T1 (de) Regionspezifische determinanten fuer vitamin-k abhaengiges knochenprotein.
ES2054769T3 (es) Polipeptidos hiv-2 recombinantes.
DE69033128D1 (de) Für leberzellkarzinom spezifisches onkogen
ES2133269T3 (es) Gen receptor del factor de crecimiento derivado de plaquetas de tipo oc.
DE3585358D1 (de) Herstellung von einschlussproteinfragmenten von menschlichem t-zellen-leukemia-(lymphotropischem)-retrovirus (htlv-1) in bakterien und verwendung fuer die seroloimologische pruefung von menschlicher lymphoid-malignitaet.
ES2058259T3 (es) Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2.
ES2094124T3 (es) Ensayo-inmunologico de anticuerpos contra hiv.
ES8604693A1 (es) Un metodo para detectar un anticuerpo o un antigeno contenido en una muestra de fluido de origen biologico.
ES8605296A1 (es) Procedimiento de producir factor viii-r humano
DE3870035D1 (de) Biologisches diagnostisches testsystem.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20100528